A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Clinical trial NCT06245408 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06245408
Sponsor: Amgen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sjögren's Syndrome (SS)

Start date: 2024-04-08
Primary completion: 2026-10-22
Enrollment: 434

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.